The Clínic has treated 624 cases since the beginning of the year, an increase of 6,3% over last year’s period. A quarter of the women treated who are1
These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative diseases1
A recent article describes how a new biomaterial has shown promising results in regenerating cartilage. Human studies and long-term results are still1
Last Wednesday, 13 November, the dining facility of the Esther Koplowitz Centre (CEK), IDIBAPS headquarters, hosted a solidarity breakfast to support1
Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most inf1
This group of non-Hodgkin B-cell lymphomas has characteristics that fall between two of the most common and aggressive lymphomas affecting paediatric1
The Neonatal Intensive Care Unit (NICU) at the Maternitat Centre has been offering music therapy sessions to its patients and families for over 3 yea1
Over the next three years, the chosen project, led by Roger Gomis (IRB) in consortium with Aleix Prat (Clínic-IDIBAPS), will study the factors that c1
The tool generates a report from an MRI that indicates whether patients could develop prostate cancer. The project has loaded on 3.7 million medical1
A recent article in the journal, Cell, described the case of a patient who had managed to cure himself of type 1 diabetes using his own modified cell1
